申请人:Glenmark Pharmaceuticals S.A.
公开号:US08119647B2
公开(公告)日:2012-02-21
The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3.
本发明提供了瞬时受体电位香草酰基转移酶(TRPV)调节剂。特别地,本文所描述的化合物可用于治疗或预防受TRPV3调节的疾病、病况和/或疾病。本文还提供了制备所述化合物的过程,用于其合成的中间体,其制药组成物以及治疗或预防受TRPV3调节的疾病、病况和/或疾病的方法。